Skip to content

GENEXPERT

Active Private limited companyfounded 2002active for 24 yearsRue Emile Montoisy 4, 1460 IttreKBO/BCE: BE 0477.248.809

Lifetime

18 annual accounts with figures on one time axis, 24 filings since 2002
peak of €99,785 in 2021
€50,868▼ 14.3%
lowest -€49,277 in 2022
€23,889▼ 43.5%
peak of €217,926 in 2021
€207,208▲ 13.0%
€17,819▼ 81.3%
peak of 4 FTE in 2015
-not published
Board1 name since 2002
1 director
Owners
  
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €59,347 to €50,868Result from €42,306 to €23,889Equity from €183,319 to €207,208Debts from €95,230 to €17,819

Key points

from the 2025 annual accounts

Liquidity

7.75 was 2.10 in 2024

Short-term debts fell from €93,564 to €17,819.

Filings

24 annual accounts since 2002
AprilJune31 JulyOctober20102020

Six of the last ten came late. The 2019 accounts came in latest, 59 days after the end of the period.

Position in the sector

92.1%

Higher solvency than 86% of companies in human health. Sector median 63.0% · 21,337 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as GENEXPERT has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for GENEXPERT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 06-12-2023
  • 100%annual accounts 2017
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0477248809
Purpose change “Hippothérapie; Arboriculture fruitière; Hébergement touristique” (deed in French) · Gazette deed
resigns as manager reappointed as director · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 06-12-2023 · Gazette deed
Capital increase of €72,000 to €90,600 The capital rose from €18,600 to €90,600 · “La publication et la diffusion d'articles et d'ouvrages scientifiques pluridisciplinaires; La…” (deed in French) · General meeting of 17-12-2013 · Gazette deed
All 41 events

Comparable companies

same main activity, similar in size and age
Company
GENEXPERT Ittre €225,027 €50,868 92.1% -
ORTHOSURGE Woluwe-Saint-Lambert €232,782 €51,213 31.5% -
Dr. med. Jan Bolt Kruisem €226,194 €55,502 3.1% -
PRESENT Waterloo €278,860 €46,381 59.7% -
NEUROFI CONSULT Ottignies-Louvain-la-Neuve €265,655 €58,742 50.7% -
STAINIER MEDICAL Ottignies-Louvain-la-Neuve €200,105 €61,712 49.8% -
HUB-EYES Ottignies-Louvain-la-Neuve €253,247 €63,189 31.8% -

These companies have the same main activity as GENEXPERT: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €200,000 and €279,000, founded between 1998 and 2005.

Official details

Source: KBO
Status
Active since 03-04-2002Normal situation
Activity
Specialist medical practiceNACE 86220and 2 others
Establishment unit
2.229.159.1761460 Ittre, since 26-03-2002
Financial year end
31 December
Peppol
Reachable since 25-11-2025
Company details

Annual accounts 2025

≈ €110,000estimated
€225,027▼ 19.2%
Filing
Filed on 31-08-2026
Financials

Insights on GENEXPERT

GENEXPERT files the micro format. That format states no turnover. The gross margin rose from €39,166 in 2008 to €50,868 in 2025.

The balance sheet grew most from 2013 to 2014 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about GENEXPERT

What is the company number of GENEXPERT?
The company number of GENEXPERT is 0477.248.809. The VAT number is the same number with BE in front: BE 0477.248.809.
Where is GENEXPERT based?
The registered office is at Rue Emile Montoisy 4, 1460 Ittre.Company details
What does GENEXPERT do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of GENEXPERT?
GENEXPERT is a private limited company (BV).
When was GENEXPERT founded?
GENEXPERT was founded on 03-04-2002.
Is GENEXPERT still active?
Yes, GENEXPERT is an active enterprise in the KBO register.
How many employees does GENEXPERT have?
GENEXPERT had an average of 0.4 full-time equivalents in financial year 2018, according to the filed annual accounts.Financials
What is the turnover of GENEXPERT?
The turnover in financial year 2025 is ≈ €110,000. This figure is estimated from the gross margin of €50,868 and 33 comparable companies (NACE 862). It probably lies between €86,000 and €140,000.
Is GENEXPERT profitable?
In financial year 2025, GENEXPERT made a profit of €23,889.
Where can I find the annual accounts of GENEXPERT?
GENEXPERT filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of GENEXPERT due?
GENEXPERT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.